文献速递心胸血管麻醉

围术期口服咖啡因不能预防心脏瓣膜手术后房颤

Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: A randomised controlled clinical trial.
PubMed 文献 · Eur J Anaesthesiol · 2018-01-01

结果显示咖啡因组与安慰剂组术后住院期间房颤发生率相似(33% vs 29%,P=0.67),但咖啡因组术后恶心呕吐发生率更高(27% vs 7%,P=0.005)。

要点

  • 围术期口服咖啡因不能降低体外循环心脏瓣膜术后房颤发生率
  • 咖啡因组术后恶心呕吐发生率显著高于安慰剂组
  • 基线及术后腺苷血浆水平与主要结局显著相关

核心结论

  • 口服咖啡因不能预防体外循环心脏瓣膜手术后房颤,且增加术后恶心呕吐发生率。

研究设计与样本

  • 干预为围术期口服咖啡因400 mg每8小时一次共2天或安慰剂。
  • 50例子组评估腺苷血浆浓度和咖啡因药代动力学。

主要发现

  • 研究因无效被数据监察委员会在中期分析后终止。
  • 住院期间房颤发生率咖啡因组与安慰剂组相似(33% vs 29%,P=0.67)。
  • 术后前3天房颤发生率两组相似(18% vs 15%,P=0.60)。
  • 基线和术后腺苷血浆水平与主要结局显著相关,两组间腺苷水平相似。
  • 咖啡因组术后恶心呕吐发生率更高(27% vs 7%,P=0.005)。

临床怎么用

  • 不应基于本试验结果使用围术期口服咖啡因预防心脏瓣膜术后房颤。
  • 需注意咖啡因可能增加术后恶心呕吐风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Raised plasma levels of endogenous adenosine after cardiac surgery using cardiopulmonary bypass (CPB) have been related to the incidence of postoperative atrial fibrillation (POAF). OBJECTIVE: We wished to assess if caffeine, an adenosine receptor antagonist could have a beneficial effect on the incidence of POAF. DESIGN: A randomised controlled study. SETTING: Single University Hospital. PATIENTS: One hundred and ten patients scheduled for heart valve surgery with CPB. INTERVENTIONS: We randomly assigned patients to receive peri-operative oral caffeine (400 mg every 8 h for 2 days) or placebo. Adenosine plasma concentrations and caffeine pharmacokinetic profile were evaluated in a subgroup of 50 patients. MAIN OUTCOME MEASURES: The primary endpoint was the rate of atrial fibrillation during postoperative hospital stay. RESULTS: The current study was stopped for futility by the data monitoring board after an interim analysis. The incidence of atrial fibrillation was similar in the caffeine and in the placebo group during hospital stay (33 vs. 29%, P = 0.67) and the first 3 postoperative days (18 vs. 15%; P = 0.60). Basal and postoperative adenosine plasma levels were significantly associated with the primary outcome. Adenosine plasma levels were similar in the two treatment groups. Caffeine administration was associated with a higher incidence of postoperative nausea and vomiting (27 vs. 7%, P = 0.005). CONCLUSION: Oral caffeine does not prevent POAF after heart valve surgery with CPB but increased the incidence of postoperative nausea and vomiting. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, no.: NCT01999829.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Lagier D, Nee L, Guieu R, et al. Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: A randomised controlled clinical trial. Eur J Anaesthesiol. 2018. PMID: 29702502. doi:10.1097/EJA.0000000000000824

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。